Patents by Inventor Hud Lawrence Risley

Hud Lawrence Risley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bifunctional cytotoxic agents
    Patent number: 10391182
    Abstract: Cytotoxic dimers comprising CBI-based and/or CPI-based sub-units, antibody drug conjugates comprising such dimers, and to methods for using the same to treat cancer and other conditions.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: August 27, 2019
    Assignee: Pfizer Inc.
    Inventors: Andreas Maderna, Matthew David Doroski, Zecheng Chen, Hud Lawrence Risley, Jeffrey Michael Casavant, Christopher John O'Donnell, Alexander M. Porte, Chakrapani Subramanyam
  • BIFUNCTIONAL CYTOTOXIC AGENTS
    Publication number: 20180339060
    Abstract: Cytotoxic dimers comprising CBI-based and/or CPI-based sub-units, antibody drug conjugates comprising such dimers, and to methods for using the same to treat cancer and other conditions.
    Type: Application
    Filed: August 2, 2018
    Publication date: November 29, 2018
    Applicant: PFIZER INC.
    Inventors: Andreas MADERNA, Matthew David DOROSKI, Zecheng CHEN, Hud Lawrence RISLEY, Jeffrey Michael CASAVANT, Christopher John O'DONNELL, Alexander M. PORTE, Chakrapani SUBRAMANYAM
  • Bifunctional cytotoxic agents
    Patent number: 10086085
    Abstract: Cytotoxic dimers comprising CBI-based and/or CPI-based sub-units, antibody drug conjugates comprising such dimers, and to methods for using the same to treat cancer and other conditions.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: October 2, 2018
    Assignee: Pfizer Inc.
    Inventors: Andreas Maderna, Matthew David Doroski, Zecheng Chen, Hud Lawrence Risley, Jeffrey Michael Casavant, Christopher John O'Donnell, Alexander M. Porte, Chakrapani Subramanyam
  • BIFUNCTIONAL CYTOTOXIC AGENTS
    Publication number: 20150209445
    Abstract: Cytotoxic dimers comprising CBI-based and/or CPI-based sub-units, antibody drug conjugates comprising such dimers, and to methods for using the same to treat cancer and other conditions.
    Type: Application
    Filed: January 26, 2015
    Publication date: July 30, 2015
    Inventors: Andreas MADERNA, Matthew David DOROSKI, Zecheng CHEN, Hud Lawrence RISLEY, Jeffrey Michael CASAVANT, Christopher John O'DONNELL, Alexander M. PORTE, Chakrapani SUBRAMANYAM
  • Monobactams
    Publication number: 20150148326
    Abstract: The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.
    Type: Application
    Filed: January 29, 2015
    Publication date: May 28, 2015
    Inventors: Matthew F. Brown, Mark J. Mitton-Fry, Seungil Han, Manjinder Lall, Mark Plummer, Hud Lawrence Risley, Veerabahu Shanmugasundaram, Jeremy Starr
  • Monobactams
    Publication number: 20130252935
    Abstract: The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.
    Type: Application
    Filed: February 27, 2013
    Publication date: September 26, 2013
    Applicant: PFIZER INC.
    Inventors: Matthew F. Brown, Mark J. Mitton-Fry, Seungil Han, Manjinder Lall, Mark Plummer, Hud Lawrence Risley, Veerabahu Shanmugasundaram, Jeremy Starr
  • MONOBACTAMS
    Publication number: 20120302542
    Abstract: The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.
    Type: Application
    Filed: November 29, 2011
    Publication date: November 29, 2012
    Inventors: Matthew F. Brown, Mark J. Mitton-Fry, Seungil Han, Manjinder Lall, Mark Plummer, Hud Lawrence Risley, Veerabahu Shanmugasundaram, Jeremy Starr
  • COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES
    Publication number: 20100029710
    Abstract: Compounds of following formula (I) are provided that have both angiotensin II receptor antagonist activity and PPARy agonist activity. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment of diseases with the compounds including type 2 diabetes, insulin resistance, hyperinsulinemia, hyperlipidemia, hypertriglyceridemia, metabolic syndrome, congestive heart failure, and hypertension.
    Type: Application
    Filed: December 3, 2007
    Publication date: February 4, 2010
    Applicant: Pfizer Products Inc.
    Inventors: Christopher Franklin Bigge, Agustin Casimiro-Garcia, Chitase Lee, Hud Lawrence Risley, Robert Philip Schaum